US › Healthcare

Biotricity Inc (BTCY)

US · Healthcare · Medical Devices

$0.10-10.91%

Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue

$4.3M

Revenue YoY

+9.7%

Net profit

$-324,182

Profit YoY

+51.8%

EPS

$-0.04

EPS estimate

$-0.11

Net margin

-7.6%

EPS came in at -0.04 against a street estimate of -0.11 — a beat of 63.6%.

Key statistics

Market cap

$2.2M

Forward P/E

0.0

P/B

29.92

Book value

$-1.21

EPS (TTM)

$-0.12

52-week high

$0.75

52-week low

$0.09

50-day MA

$0.12

200-day MA

$0.27

Beta

1.15

Analyst view

Analysts rate Biotricity Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $4.00.

Shareholding

Insiders

1.17%

Institutions

2.99%

Largest institutional holders

Fund	Stake
Strengthening Families & Communities, LLC	0.17%
Sfam, LLC	0.06%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Biotricity Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.